Specialty pharmacy

A specialty pharmacy is a pharmacy that dispenses specialty drugs (high-cost preparations typically requiring special handling, patient monitoring, or limited distribution) including oncology agents, biologics, rare-disease preparations, REMS-restricted drugs, and increasingly GLP-1 receptor agonists. Specialty pharmacies operate under distinct network contracts with PBMs and manufacturers (often as part of Limited Distribution Drug networks), face concentrated audit risk on individual high-dollar claims, and frequently coordinate REMS compliance, prior authorization, and patient-specific clinical monitoring.

How specialty pharmacy operations work

Specialty pharmacies operate under contracts that differ from general retail pharmacy contracts in three ways. First, the network is narrower: PBMs and manufacturers credential a defined set of pharmacies for each specialty drug category, often through Limited Distribution Drug arrangements. Second, the dispensing protocol is more rigorous: REMS compliance, patient enrollment, lab monitoring, clinical adherence reporting, and contract-specific dispensing windows. Third, the economics differ: AWP-discount or fee-for-service reimbursement on individual high-dollar claims rather than the MAC-driven volume model that governs retail generic dispensing.

When specialty pharmacy oversight applies

Specialty pharmacy oversight applies whenever the dispensing pharmacy is credentialed in a specialty network for a specialty drug category. PBM audit focus on specialty pharmacies typically emphasizes individual claim documentation, REMS compliance, prior-authorization validity, and clinical-monitoring evidence. Manufacturer audits run on a parallel track focused on the LDD network contract terms. The audit cadence is often more frequent than retail pharmacy audits because individual claim values are higher.

The specialty pharmacy's exposure

Per-claim recoupment exposure is substantial because individual specialty claims can run from $5,000 to over $50,000. A 20-claim audit sample with statistical extrapolation across the claim universe can produce six- and seven-figure recoupment demands. Network exposure is acute: termination from a specialty network typically eliminates the pharmacy's access to the affected drug category. The defense framework focuses on contemporaneous clinical documentation, REMS compliance records, prior-authorization documentation, and the statistical methodology challenge where the audit applies extrapolation across the high-dollar claim universe.

Related terms

• Limited Distribution Drug The manufacturer-restricted network framework most specialty pharmacies operate under.
• REMS The FDA safety program framework that governs specialty drug dispensing in many categories.
• GLP-1 The drug class that has expanded the specialty pharmacy dispensing footprint.
• Prior authorization The PBM approval process that precedes most specialty claim dispensing.

See also

• Practice area
  Specialty Pharmacy Audit Defense

  The full specialty pharmacy defense framework spanning PBM audit, LDD network defense, and REMS compliance.

• Practice area
  PBM Audit Defense

  PBM audit defense framework where specialty audit defense overlaps with generic-pharmacy audit defense.